Expression of the G6PC transgene expression was well above the threshold of 3% of normal G6Pase activity that prevented tumor formation from the effects of GSD Ia in G6pc–/– mice (5, 26), given that 8% of normal G6Pase activity was demonstrated for the best-treated group (Figure 4A). The gene discussed is G6PC1; the disease is neoplasm.